Literature DB >> 11120655

Gluconeogenesis in moderately and severely hyperglycemic patients with type 2 diabetes mellitus.

G Boden1, X Chen, T P Stein.   

Abstract

We tested the generally accepted concept that increased gluconeogenesis (GNG) and endogenous glucose production (EGP) are the main reasons for postabsorptive hyperglycemia in patients with type 2 diabetes mellitus (T2DM). GNG was measured with the (2)H(2)O method by use of both the C5-to-C2 ratio (C5/C2, with gas chromatography-mass spectrometry) and the C5-to-(2)H(2)O ratio (C5/(2)H(2)O, with isotope ratio mass spectrometry), and EGP was measured with 3-[(3)H]glucose in 27 patients with T2DM [13 with fasting plasma glucose (FPG) >10 mM and 14 with FPG <10 mM] and in 7 weight- and age-matched nondiabetic controls. The results showed 1) that GNG could be determined accurately with (2)H(2)O by using either C5/C2 or C5/(2)H(2)O; 2) that whereas after an overnight fast of 16 h, GNG was higher in the entire group of patients with T2DM than in controls (6.4 vs. 5.0 micromol. kg(-1). min(-1) or 60.4 vs. 51.4% of EGP, P < 0.02), GNG was within normal limits (less than the mean +/- 2 SD of controls or <65.3%) in 11/14 (79%) patients with mild to moderate hyperglycemia (FPG <10 mM) and in 5/13 (38%) of patients with severe hyperglycemia (FPG 10-20 mM); 3) that elevated GNG in T2DM was associated with a 43% decrease in prehepatic insulin secretion, i.e., with hepatic insulin deficiency; and 4) that FPG correlated significantly with glucose clearance (insulin resistance) (r = 0.70) and with GNG (r = 0.50) or EGP (r = 0.45). We conclude 1) that peripheral insulin resistance is at least as important as GNG (and EGP) as a cause of postabsorptive hyperglycemia in T2DM and 2) that GNG and EGP in T2DM are increased under conditions of significant hepatic insulin deficiency and thus probably represent a late event in the course of T2DM.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11120655     DOI: 10.1152/ajpendo.2001.280.1.E23

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  40 in total

1.  Diurnal rhythm in endogenous glucose production is a major contributor to fasting hyperglycaemia in type 2 diabetes. Suprachiasmatic deficit or limit cycle behaviour?

Authors:  J Radziuk; S Pye
Journal:  Diabetologia       Date:  2006-05-16       Impact factor: 10.122

2.  Physical exercise reduces pyruvate carboxylase (PCB) and contributes to hyperglycemia reduction in obese mice.

Authors:  Vitor Rosetto Muñoz; Rafael Calais Gaspar; Barbara Moreira Crisol; Guilherme Pedron Formigari; Marcella Ramos Sant'Ana; José Diego Botezelli; Rodrigo Stellzer Gaspar; Adelino S R da Silva; Dennys Esper Cintra; Leandro Pereira de Moura; Eduardo Rochete Ropelle; José Rodrigo Pauli
Journal:  J Physiol Sci       Date:  2017-07-14       Impact factor: 2.781

3.  Inhibiting gluconeogenesis prevents fatty acid-induced increases in endogenous glucose production.

Authors:  Sylvia Kehlenbrink; Julia Tonelli; Sudha Koppaka; Visvanathan Chandramouli; Meredith Hawkins; Preeti Kishore
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-05-05       Impact factor: 4.310

4.  Roux-en-Y gastric bypass surgery improves hepatic glucose metabolism and reduces plasma kisspeptin levels in morbidly obese patients with type 2 diabetes.

Authors:  C Robb Flynn; Vance L Albaugh; Robyn A Tamboli; Justin M Gregory; Amma Bosompem; Reem M Sidani; Jason J Winnick
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-11-11       Impact factor: 4.052

Review 5.  Fatty acid-induced inflammation and insulin resistance in skeletal muscle and liver.

Authors:  Guenther Boden
Journal:  Curr Diab Rep       Date:  2006-06       Impact factor: 4.810

Review 6.  Mechanisms of Insulin Action and Insulin Resistance.

Authors:  Max C Petersen; Gerald I Shulman
Journal:  Physiol Rev       Date:  2018-10-01       Impact factor: 37.312

7.  Six weeks' sebacic acid supplementation improves fasting plasma glucose, HbA1c and glucose tolerance in db/db mice.

Authors:  M Membrez; C J Chou; F Raymond; R Mansourian; M Moser; I Monnard; C Ammon-Zufferey; K Mace; G Mingrone; C Binnert
Journal:  Diabetes Obes Metab       Date:  2010-12       Impact factor: 6.577

8.  Coordinate Transcriptomic and Metabolomic Effects of the Insulin Sensitizer Rosiglitazone on Fundamental Metabolic Pathways in Liver, Soleus Muscle, and Adipose Tissue in Diabetic db/db Mice.

Authors:  Sabrina Le Bouter; Marianne Rodriguez; Nolwen Guigal-Stephan; Sophie Courtade-Gaïani; Laura Xuereb; Catherine de Montrion; Vincent Croixmarie; Thierry Umbdenstock; Claire Boursier-Neyret; Michel Lonchampt; Manuel Brun; Catherine Dacquet; Alain Ktorza; Brian-Paul Lockhart; Jean-Pierre Galizzi
Journal:  PPAR Res       Date:  2010-10-10       Impact factor: 4.964

9.  Additional evidence that transaldolase exchange, isotope discrimination during the triose-isomerase reaction, or both occur in humans: effects of type 2 diabetes.

Authors:  Rita Basu; Visvanthan Chandramouli; William Schumann; Ananda Basu; Bernard R Landau; Robert A Rizza
Journal:  Diabetes       Date:  2009-04-14       Impact factor: 9.461

10.  Effects of type 2 diabetes on insulin secretion, insulin action, glucose effectiveness, and postprandial glucose metabolism.

Authors:  Ananda Basu; Chiara Dalla Man; Rita Basu; Gianna Toffolo; Claudio Cobelli; Robert A Rizza
Journal:  Diabetes Care       Date:  2009-02-05       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.